Chronic inflammation, joint replacement and malignant lymphoma

Journal of Bone and Joint Surgery - Series B

Volumn 90, Issue 1, 2008, Pages 7-10

  Lidgren, L ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTHROPLASTY; ARTICLE; CHRONIC INFLAMMATION; CYTOTOXICITY; FOLLICULAR LYMPHOMA; HUMAN; IMMUNE SYSTEM; JOINT PROSTHESIS; KNEE ARTHROPLASTY; LYMPHOCYTE FUNCTION; LYMPHOMA; METAL IMPLANTATION; NONHODGKIN LYMPHOMA; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; TOTAL HIP PROSTHESIS;

ARTHROPLASTY, REPLACEMENT; CHROMIUM; CHRONIC DISEASE; COBALT; DENMARK; FEMALE; FINLAND; HUMANS; INFLAMMATION; JOINT PROSTHESIS; LEUKOCYTE DISORDERS; LYMPHOCYTES; LYMPHOMA; MALE; METALS, HEAVY; NEW ZEALAND; RISK ASSESSMENT; SWEDEN;

EID: 38749089104     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.90B1.19823     Document Type: Article

References (62)

1. Delgado-Rodríguez M, Llorca J. Bias. J Epidemiol Community Health 2004;58:635-41.
2. Lewold S, Olsson H, Gustafson P, Rydholm A, Lidgren L. Overall cancer incidence not increased after prosthetic knee replacement: 14,551 patients followed for 66,622 person-years. Int J Cancer 1996;68:30-3.
3. Paavolainen P, Pukkala E, Pulkkinen P, Visuri T. Cancer incidence after total knee arthroplasty: a nationwide Finnish cohort from 1980 to 1996 involving 9,444 patients. Acta Orthop Scand 1999;70:609-17.
4. Olsen JH, McLaughlin JK, Nyrén O, et al. Hip and knee implantations among patients with osteoarthritis and risk of cancer: a record-linkage study from Denmark. Int J Cancer 1999;81:719-22.
5. Gillespie WJ, Frampton CM, Henderson RJ, Ryan PM. The incidence of cancer following total hip replacement. J Bone Joint Surg [Br] 1988;70-B:539-42.
6. Visuri T, Pukkala E, Paavolainen P, Pulkkinen P, Riska EB. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin Orthop 1996;329(Suppl):280-9.
7. Nyrén O, McLaughlin JK, Gridley G, et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1995;87:28-33.
8. Visuri TI, Pukkala E, Pulkkiinen P, Paavolainen P. Cancer incidence and causes of death among total hip replacement patients: a review based on Nordic cohorts with a special emphasis on metal-on-metal bearings. Proc Inst Mech Eng [H] 2006;220:399-407.
9. Visuri T, Koskenvuo M. Cancer risk after Mckee-Farrar total hip replacement. Orthopedics 1991;14:137-42.
10. No authors listed. The Swedish Knee Arthroplasty Register. www.knee.se (date last accessed 11 October 2007).
11. No authors listed. The Swedish Hip Arthroplasty Register. www.jru.orthop.gu.se (date last accessed 11 October 2007).
12. No authors listed. Swedish Cancer Register http://www. socialstyrelsen.se/en/Statistics/Statistical-databases.htm (date last accessed 26 November 2007).
13. Askling J, Fored CM, Baecklund E, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1414-20.
14. Baecklund E, Sundström C, Ekbom A, et al. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 2003;48:1543-50.
15. Bäcklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L. Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol 2004;16:254-61.
16. Whelan P. Link between rheumatoid arthritis and cancer. Z Rheumatol 2006;65:497-504 (in German).
17. Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol 2006;18:129-34.
18. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50:1262-9.
19. Pillemer SR. Lymphoma and other malignancies in primary Sjögren's syndrome. Ann Rheum Dis 2006;65:704-6.
20. Theander E, Henriksson G, Ljungberg O, et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803.
21. Heath JC, Freeman MA, Swanson SA. Carcinogenic properties of wear particles from prostheses made in cobalt-chromium alloy. Lancet 1971;1:564-6.
22. Rae T. The haemolytic action of particulate metals (Cd, Cr, Co, Fe, Mo, Ni, Ta, Ti, Zn, Co-Cr alloy). J Pathol 1978;125:81-9.
23. Snow ET. Metal carcinogenesis: mechanistic inmplications. Pharmacol Ther 1992;53:31-65.
24. Sunderman FW Jr. Recent advances in metal carcinogenesis. Ann Clin Lab Sci 1984;14:93-122.
25. Goodman S, Aspenberg P, Song Y, et al. Tissue ingrowth and differentiation in the bone-harvest chamber in the presence of cobalt-chromium-alloy and high-density-polyethylene particles. J Bone Joint Surg [Am] 1995;77-A:1025-35.
26. Steens W, von Foerster G, Katzer A. Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip: a case report. Acta Orthop 2006;77:830-2.
27. Cobb AG, Schmalzreid TP. The clinical significance of metal ion release from cobalt-chromium metal-on-metal hip joint arthroplasty. Proc Inst Mech Eng [H] 2006;220:385-98.
28. Sargeant A, Goswami T, Swank M. Ion concentrations from hip implants. J Surg Orthop Adv 2006;15:113-4.
29. Virtanen S. Metal release mechanisms in hip replacement. Acta Orthop 2006;77:695-6.
30. McDonald SJ. Can a safe level for metal ions in patients with metal-on-metal total hip arthroplasties be determined? J Arthroplasty 2004;19(Suppl 3)71-7.
31. Keegan GM, Learmonth ID, Case CP. Orthopaedic metals and their potential toxicity in the arthroplasty patient: a review of current knowledge and future strategies. J Bone Joint Surg [Br] 2007;89-B:567-73.
32. Rae T. The toxicity of metals used in orthopaedic prostheses: an experimental study using cultured human synovial fibroblasts. J Bone Joint Surg [Br] 1981;63-B:435-40.
33. MacDonald SJ, Brodner W, Jacobs JJ. A consensus paper on metal ions in metal-on-metal hip arthroplasties. J Arthroplasty 2004;19(Suppl 3):12-16.
34. Daniel J, Ziaee H, Pynsent PB, McMinn DJ. The validity of serum levels as a surrogate measure of systemic exposure to metal ions in hip replacement. J Bone Joint Surg [Br] 2007;89-B:736-41.
35. Cuckler JM. The rationale for metal-on-metal total hip arthroplasty. Clin Orthop 2005;441:132-6.
36. Daniel J, Ziaee H, Pradhan C, Pynsent PB, McMinn DJ. Blood and urine metal ion levels in young and active patients after Birmingham hip resurfacing arthroplasty: four-year results of a prospective longitudinal study. J Bone Joint Surg [Br] 2007;89-B:169-73.
37. Back DL, Young DA, Shimmin AJ. How do serum cobalt and chromium levels change after metal-on-metal hip resurfacing? Clin Orthop 2005;438:177-81.
38. Brodner W, Bitzan P, Meisinger V, et al. Serum cobalt levels after metal-on-metal total hip arthroplasty. J Bone Joint Surg [Am] 2003;85-A:2168-73.
39. Case CP, Ellis L, Turner JC, Fairman B. Development of a routine method for the determination of trace metals in whole blood by magnetic sector inductively coupled plasma mass spectrometry with particular relevance to patients with total hip and knee arthroplasty. Clin Chem 2001;47:275-80.
40. Saikko V, Nevalainen J, Revitzer H, Ylinen P. Metal release from total hip articulations in vitro: substantial from CoCr/CoCr negligible from CoCr/PE, and alumina/PE. Acta Orthop Scand 1998;69:449-54.
41. Savarino L, Granchi D, Ciapetti G, et al. Ion release in patients with metal-on-metal hip bearings in total joint replacement: a comparison with metal-on-polyethylene bearings. J Biomed Mater Res 2002;63:467-74.
42. Savarino L, Greco M, Cenni E, et al. Differences in ion release after ceramic-on-ceramic and metal-on-metal total hip replacement: medium-term follow-up. J Bone Joint Surg [Br] 2006;88-B:472-6.
43. Silva M, Heisel C, Schmalzried TP. Metal-on-metal total hip replacement. Clin Orthop 2005;430:53-61.
44. Sauvé P, Mountney J, Khan T, et al. Metal ion levels after metal-on-metal Ring total hip replacement: a 30-year follow-up study. J Bone Joint Surg [Br] 2007;89-B:586-90.
45. Dunstan E, Sanghrajka AP, Tilley S, et al. Metal ion levels after metal-on-metal proximal femoral replacements: a 30-year follow-up. J Bone Joint Surg [Br] 2005;87-B:628-31.
46. Khan M, Takahashi T, Kuiper JH, et al. Current in vivo wear of metal-on-metal bearings assessed by exercise-related rise in plasma cobalt level. J Orthop Res 2006;24:2029-35.
47. De Haan R, Campbell P, Reid S, Skipor AK, De Smet K. Metal ion levels in a triathlete with a metal-on-metal resurfacing arthroplasty of the hip. J Bone Joint Surg [Br] 2007;89-B:538-41.
48. Clarke MT, Lee PT, Arora A, Villar RN. Levels of metal ions after small- and large-diameter metal-on-metal hip arthroplasty. J Bone Joint Surg [Br] 2003;85-B:913-7.
49. Witzleb WC, Ziegler J, Krummenauer F, Neumeister V, Guenther KP. Exposure to chromium, cobalt and molybdenum from metal-on-metal total hip replacement and hip resurfacing arthroplasty. Acta Orthop 2006;77:697-705.
50. Vendittoli PA, Mottard S, Roy AG, Dupont C, Lavigne M. Chromium and cobalt ion release following the Durom high carbon content, forged metal-on-metal surface replacement of the hip. J Bone Joint Surg [Br] 2007;89-B:441-8.
51. Ziaee H, Daniel J, Datta AK, Blunt S, McMinn DJ. Transplacental transfer of cobalt and chromium in patients with metal-on-metal hip arthroplasty: a controlled study. J Bone Joint Surg [Br] 2007;89-B:301-5.
52. Grübl A, Marker M, Brodner W, et al. Long-term follow-up of metal-on-metal total hip replacement. J Orthop Res 2007;25:841-8.
53. Catelas I, Campbell PA, Bobyn JD, Medley JB, Huk OL. Wear particles from metal-on-metal total hip replacements: effects of implant design and implantation time. Proc Inst Mech Eng [H] 2006;220:195-208.
54. Davies AP, Willert HG, Campbell PA, Learmonth ID, Case CP. An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg [Am] 2005;87-A:18-27.
55. Witzleb WC, Hanisch U, Kolar N, Krummenauer F, Guenther KP. Neo-capsule tissue reactions in metal-on-metal hip arthroplasty. Acta Orthop 2007;78:211-20.
56. Pearle AD, Crow MK, Rakshit DS, Wohlgemuth J, Nestor BJ. Distinct inflammatory gene pathways induced by particles. Clin Orthop 2007;458:194-201.
57. Ladon D, Doherty A, Newson R, et al. Changes in metal levels and chromosome aberrations in the peripheral blood of patients after metal-on-metal hip arthroplasty. J Arthroplasty 2004;19(Suppl 3)78-83.
58. Hart AJ, Hester T, Sinclair K, et al. The association between metal ions from hip resurfacing and reduced T-cell counts. J Bone Joint Surg [Br] 2006;88-B:449-54.
59. Dunstan E, Ladon D, Whittingham-Jones P. Chromosomal aberrations in the peripheral blood of patients with metal-on-metal hip bearings. Procs British Orthopaedic Association Annual Congress, 2006.
60. Stenstad H. Effector T cell homing to the small intestinal mucosa. Department of Experimental Medical Science, Section for Immunology. Doctoral dissertation. Lund: Lund University, 2007.
61. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. J Clin Oncol 1998;16:2780-95.
62. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004;351:2159-69.